Comprehensive analysis of PD‐L1 in non‐small cell lung cancer with emphasis on survival benefit, impact of driver mutation and histological types, and archival tissue

BACKGROUND: The aim of the study was to assess programmed death‐ligand‐1 (PD‐L1) expression in different histological types and gene mutation status of patients with non‐small cell lung cancer (NSCLC). METHODS: A total of 4062 pathology‐confirmed lung cancer patients were retrospectively screened at...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Chin‐Chou, Huang, Kuo‐Tung, Chang, Huang‐Chih, Tseng, Chia‐Cheng, Lai, Chien‐Hao, Lan, Jui, Liu, Ting‐Ting, Huang, Chao‐Cheng, Lin, Meng‐Chih
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720620/
https://www.ncbi.nlm.nih.gov/pubmed/34841687
http://dx.doi.org/10.1111/1759-7714.14216

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8720620/
https://www.ncbi.nlm.nih.gov/pubmed/34841687
http://dx.doi.org/10.1111/1759-7714.14216

Ejemplares similares